1. Home
  2. GRC vs OLMA Comparison

GRC vs OLMA Comparison

Compare GRC & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gorman-Rupp Company (The)

GRC

Gorman-Rupp Company (The)

HOLD

Current Price

$61.25

Market Cap

1.7B

Sector

Industrials

ML Signal

HOLD

Logo Olema Pharmaceuticals Inc.

OLMA

Olema Pharmaceuticals Inc.

HOLD

Current Price

$13.79

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRC
OLMA
Founded
1933
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Fluid Controls
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
2.0B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
GRC
OLMA
Price
$61.25
$13.79
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
$44.89
AVG Volume (30 Days)
124.9K
1.6M
Earning Date
04-23-2026
03-16-2026
Dividend Yield
1.22%
N/A
EPS Growth
32.03
15.00
EPS
2.02
N/A
Revenue
$682,389,000.00
N/A
Revenue This Year
$6.62
N/A
Revenue Next Year
$4.66
$347.47
P/E Ratio
$31.00
N/A
Revenue Growth
3.44
N/A
52 Week Low
$30.87
$2.86
52 Week High
$68.02
$36.26

Technical Indicators

Market Signals
Indicator
GRC
OLMA
Relative Strength Index (RSI) 48.96 27.43
Support Level $56.98 $4.15
Resistance Level $67.61 $27.38
Average True Range (ATR) 2.36 1.07
MACD -0.01 0.00
Stochastic Oscillator 51.50 16.67

Price Performance

Historical Comparison
GRC
OLMA

About GRC Gorman-Rupp Company (The)

Gorman-Rupp Co designs, manufactures, and globally sells pumps & pump systems for use in water, wastewater, construction, dewatering, industrial, petroleum, original equipment, agriculture, fire protection, heating, ventilating & air conditioning, military, and other liquid-handling applications. It operates in one business segment, the manufacture & sale of pumps and pump systems, and generates revenue from the same. Geographically, it generates the majority of revenue from the United States.

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

Share on Social Networks: